OABI

OmniAb Inc.

OABI, USA

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

https://www.omniab.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
OABI
stock
OABI

OmniAb (NASDAQ: OABI) debuts OmniUltra chicken platform for ultralong CDRH3 Stock Titan

Read more →
OABI
stock
OABI

OmniAb Insiders Enjoying US$277k Appreciation On US$1.59m Investment simplywall.st

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$7.3333

Analyst Picks

Strong Buy

6

Buy

2

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.89

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-5.96 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-5.34 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-444.17 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.12

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 42.42% of the total shares of OmniAb Inc.

1.

Whitefort Capital Management, LP.

(7.1134%)

since

2025/06/30

2.

BlackRock Inc

(4.8634%)

since

2025/06/30

3.

Vanguard Group Inc

(3.6597%)

since

2025/06/30

4.

Dimensional Fund Advisors, Inc.

(2.0241%)

since

2025/06/30

5.

Rice Hall James & Associates, LLC

(1.825%)

since

2025/06/30

6.

Vanguard Total Stock Mkt Idx Inv

(1.7959%)

since

2025/07/31

7.

Private Management Group Inc

(1.777%)

since

2025/06/30

8.

Geode Capital Management, LLC

(1.6946%)

since

2025/06/30

9.

iShares Russell 2000 ETF

(1.6256%)

since

2025/08/31

10.

Citadel Advisors Llc

(1.4814%)

since

2025/06/30

11.

State Street Corp

(1.3969%)

since

2025/06/30

12.

Kent Lake PR LLC

(1.2157%)

since

2025/06/30

13.

Jacobs Levy Equity Management, Inc.

(0.768%)

since

2025/06/30

14.

Vanguard Institutional Extnd Mkt Idx Tr

(0.7602%)

since

2025/07/31

15.

Fidelity Small Cap Index

(0.6965%)

since

2025/06/30

16.

Royce & Associates, LP

(0.6023%)

since

2025/06/30

17.

Royce Micro Cap Trust

(0.6023%)

since

2025/06/30

18.

Northern Trust Corp

(0.5813%)

since

2025/06/30

19.

Charles Schwab Investment Management Inc

(0.5781%)

since

2025/06/30

20.

Towerview LLC

(0.5773%)

since

2025/06/30

21.

JPMorgan Chase & Co

(0.5514%)

since

2025/06/30

22.

Morgan Stanley - Brokerage Accounts

(0.5332%)

since

2025/06/30

23.

iShares Russell 2000 Value ETF

(0.515%)

since

2025/08/31

24.

Renaissance Technologies Corp

(0.4915%)

since

2025/06/30

25.

Millennium Management LLC

(0.4517%)

since

2025/06/30

26.

Woodstock Corp

(0.4319%)

since

2025/06/30

27.

CREF Stock R3

(0.4099%)

since

2025/07/31

28.

Fidelity Extended Market Index

(0.3664%)

since

2025/07/31

29.

Vanguard Russell 2000 ETF

(0.3332%)

since

2025/07/31

30.

Schwab US Small-Cap ETFâ„¢

(0.3258%)

since

2025/08/30

31.

Isthmus Small Cap Core Equity

(0.3018%)

since

2025/06/30

32.

Dimensional US Targeted Value ETF

(0.2783%)

since

2025/08/29

33.

DFA US Micro Cap I

(0.2763%)

since

2025/07/31

34.

DFA US Small Cap I

(0.2762%)

since

2025/07/31

35.

DFA US Targeted Value I

(0.2617%)

since

2025/07/31

36.

State St Russell Sm Cap® Indx SL Cl I

(0.2185%)

since

2025/08/31

37.

Multi-Manager Small Cap Eq Strat Inst

(0.1995%)

since

2025/07/31

38.

Omnis US Smaller Companies A Inc

(0.1958%)

since

2025/05/31

39.

Vanguard Health Care ETF

(0.1878%)

since

2025/07/31

40.

Schwab Small Cap Index

(0.1778%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.14

EPS Estimate

-0.136

EPS Difference

-0.004

Surprise Percent

-2.9412%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

OmniAb Inc. (OABI) Stock Details & Analysis - Finnton | Finnton